Authors:
NICHOLSON N
TAITE B
PANZERKNODLE S
SALYERS A
HAAS N
SZALONY J
FREDERICK L
SULEYMANOV O
KING L
PAGE J
FEIGEN L
Citation: N. Nicholson et al., BIOLOGICAL-ACTIVITY OF ORBOFIBAN, AN ORALLY-ACTIVE INHIBITOR OF GLYCOPROTEIN IIB IIIA AND PLATELET-AGGREGATION/, Thrombosis and haemostasis, 1997, pp. 2719-2719
Authors:
BARON DA
FEIGEN L
MEYER B
CHESEBRO J
FUSTER V
BADIMON L
BADIMON JJ
Citation: Da. Baron et al., ORAL DOSING WITH THE GP-IIB IIIA RECEPTOR ANTAGONIST SC-54684A INHIBITS THE FORMATION OF PLATELET-RICH THROMBI ON DAMAGED CANINE AORTA MOUNTED IN AN EX-VIVO PERFUSION CHAMBER/, Thrombosis and haemostasis, 73(6), 1995, pp. 1332-1332
Authors:
FEIGEN L
NICHOLSON N
TAITE B
PANZERKNODLE S
SALYERS A
HAAS N
SZALONY J
ZABLOCKI J
GLENN K
KELLER B
HERIN M
JACQMIN P
LESNE M
Citation: L. Feigen et al., LONG-TERM INHIBITION OF PLATELETS IN DOGS WITH THE ORALLY-ACTIVE ALPHA(IIB)BETA(3) ANTAGONIST-SC-54684, Thrombosis and haemostasis, 69(6), 1993, pp. 1071-1071
Authors:
ZABLOCKI J
NICHOLSON N
TAITE B
PANZERKNODLE S
SALYERS A
HAAS N
SZALONY J
FEIGEN L
HERIN M
JACQMIN P
LESNE M
BOVY P
TJOENG FS
Citation: J. Zablocki et al., SELECTION OF AN ORALLY-ACTIVE GLYCOPROTEIN-IIB IIIA RECEPTOR ANTAGONIST FOR CLINICAL-TRIALS/, Thrombosis and haemostasis, 69(6), 1993, pp. 1244-1244
Authors:
CREASEY AA
CHANG ACK
FEIGEN L
WUN TC
TAYLOR FB
HINSHAW LB
Citation: Aa. Creasey et al., TISSUE FACTOR PATHWAY INHIBITOR REDUCES MORTALITY FROM ESCHERICHIA-COLI SEPTIC SHOCK, The Journal of clinical investigation, 91(6), 1993, pp. 2850-2860